Sunday, September 24, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Actelion Pharmaceuticals Ltd,
a Janssen pharmaceutical company of Johnson & Johnson
Associate Professor
Director, CTEPH Program
Associate Director, Pulmonary Hypertension Program
Professor
Mater Misericordiae University Hospital
University College Dublin
Dublin, Ireland
Professor of Pulmonary Vascular Medicine
Medical Executive Director
Kerckhoff-Klinik GmbH, Bad Nauheim
Hesse, Germany
Consultant Respiratory Physician
Director, National Pulmonary Vascular Disease Unit
Royal Papworth Hospital
NHS Foundation Trust
Cambridge, United Kingdom
Professor of Medicine
Head of the Lung Transplant and Pulmonary Hypertension Programs
UT Southwestern Medical Center
Dallas, Texas, United States
Associate Professor
Lund University
Head, Swedish Association of Pulmonary Hypertension
Lund, Sweden
Disclosure: Sonja D. Bartolome, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare
Disclosure: Sean P. Gaine, MD, PhD, FRCPI, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; United Therapeutics Corporation
Served as a speaker or a member of a speakers bureau for: Actelion Pharmaceuticals
Disclosure: Hossein Ardeschir Ghofrani, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Gossamer; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Merck Sharpe & Dohme
Served as a speaker or a member of a speakers bureau for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck Sharpe & Dohme
Received grants for clinical research from: Actelion Pharmaceuticals, Ltd; Bayer HealthCare
Disclosure: Joanna Pepke-Zaba, PhD, FRCP, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck & Co., Inc.
Served as a speaker or a member of a speakers bureau for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck & Co., Inc.
Received grants for clinical research from: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck & Co., Inc.
Disclosure: Fernando Torres, MD , has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer; United Therapeutics
Received grants for clinical research from: Altavant; Gilead; United Therapeutics
Disclosure: Göran Rådegran MD, MScEngPys, DMSc, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Acceleron; Actelion; Bayer; GlaxoSmithKline; Janssen; Merck Sharp & Dohme, Corp.; Nordic Infucare; Sanofi Aventis
Served as a speaker or a member of a speakers bureau for: Actelion; Bayer; GlaxoSmithKline; Janssen
Received grants for clinical research from: Acceleron; Actelion; Bayer; GlaxoSmithKline; Janssen; Novartis
